View Older Stories View More Recent Stories

Sep 7, 2016 11:40AM Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
Sep 1, 2016 04:01PM Ironwood Pharmaceuticals to Present at Wells Fargo 2016 Healthcare Conference
Aug 4, 2016 04:05PM Ironwood Pharmaceuticals Provides Second Quarter 2016 Investor Update
Jul 21, 2016 04:01PM Ironwood Pharmaceuticals to Host Second Quarter 2016 Investor Update Call
Jun 9, 2016 08:05AM Allergan (AGN), Ironwood Pharma's (IRWD) Linaclotide sNDA Accepted for Review by U.S. FDA
Jun 9, 2016 08:01AM Ironwood and Allergan Announce Supplemental New Drug Application for 72 mcg Linaclotide in Chronic Idiopathic Constipation Has Been Accepted for FDA Review
Jun 6, 2016 04:01PM Ironwood Pharmaceuticals to Present at Jefferies 2016 Healthcare Conference
Jun 3, 2016 06:25AM Ironwood Pharma (IRWD) Announces Closure of Lesinurad Transaction with AstraZeneca (AZN)
Jun 3, 2016 02:00AM Ironwood Pharmaceuticals Closes U.S. Transaction with AstraZeneca for Lesinurad
Jun 1, 2016 04:01PM Ironwood Pharmaceuticals to Present at Goldman Sachs 37th Annual Global Healthcare Conference
May 18, 2016 04:01PM Ironwood Pharmaceuticals to Present at 2016 UBS Global Healthcare Conference
May 17, 2016 08:00AM Ironwood Pharmaceuticals to Present Linaclotide Data at Digestive Disease Week® 2016
May 9, 2016 04:05PM Ironwood Pharmaceuticals Provides First Quarter 2016 Investor Update
May 3, 2016 04:01PM Ironwood Pharmaceuticals to Present at Bank of America Merrill Lynch 2016 Health Care Conference
Apr 27, 2016 06:09PM IMPORTANT SHAREHOLDER NOTICE: Goldberg Law PC Announces an Investigation of Claims against Ironwood Pharmaceuticals, Inc. and Advises Investors with Losses to Contact the Firm
Apr 26, 2016 05:07AM Ironwood Pharmaceuticals Enters into U.S. Licensing Agreement with AstraZeneca for Lesinurad
Apr 25, 2016 04:01PM Ironwood Pharmaceuticals to Host First Quarter 2016 Investor Update Call
Apr 7, 2016 08:09AM Ironwood Pharma (IRWD) Adds New Board Member
Apr 7, 2016 08:00AM Ironwood Pharmaceuticals Appoints Andrew Dreyfus to Board of Directors
Apr 5, 2016 09:26AM Pre-Open Stock Movers 04/05: (VRX) (MRVL) (ICPT) Higher; (PSUN) (AGN) (NATI) Lower (more...)
Apr 5, 2016 08:04AM Ironwood Pharma (IRWD) to Discontinue Development of IW-9179 for Gastroparesis
Apr 5, 2016 08:00AM Ironwood Pharmaceuticals Reports Top-Line Data from Exploratory Phase IIa Study of IW-9179 in Diabetic Gastroparesis
Mar 30, 2016 08:00AM Ironwood Pharmaceuticals to Present Clinical and Preclinical Data on sGC Stimulators at Upcoming Scientific Conferences
Mar 23, 2016 08:02AM Ironwood Pharma (IRWD) Commences IW-3718 Phase 2b in Refractory Gastroesophageal Reflux
Mar 23, 2016 08:00AM Ironwood Pharmaceuticals Initiates Phase IIb Clinical Trial of IW-3718 in Refractory Gastroesophageal Reflux Disease
Mar 9, 2016 04:01PM Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference
Mar 1, 2016 04:01PM Ironwood Pharmaceuticals to Present at Cowen and Company 36th Annual Health Care Conference
Feb 24, 2016 08:31AM Ironwood Pharma (IRWD) Partner Files NDA in Japan for Linaclotide to Treat Adults with IBS-C
Feb 24, 2016 08:00AM Ironwood Pharmaceuticals Announces Filing by Astellas of New Drug Application in Japan with Linaclotide for the Treatment of Adults with IBS-C
Feb 18, 2016 04:05PM Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2015 Investor Update
Feb 18, 2016 08:23AM Ironwood Pharma (IRWD) to Initiate Phase Ib Study of IW-1701 Following Positive Top-Line Phase Ia Data
Feb 18, 2016 08:00AM Ironwood Pharmaceuticals Progresses Vascular and Fibrotic Disease Platform with Positive Top-Line Phase Ia Data on Soluble Guanylate Cyclase Stimulator IW-1701
Feb 17, 2016 04:01PM Ironwood Pharmaceuticals to Present at 2016 RBC Capital Markets Global Healthcare Conference
Feb 4, 2016 04:01PM Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2015 Investor Update Call
Jan 11, 2016 09:14AM Ironwood Pharma (IRWD) Highlights 2015 Accomplishments; Offers Five-Year Operating Goals
Jan 11, 2016 09:00AM Ironwood Pharmaceuticals Details Strategy to Build Top-Performing Commercial Biotechnology Company
Jan 4, 2016 04:01PM Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Nov 30, 2015 04:05PM Astellas and Ironwood Report Positive Top-Line Data from Phase III IBS-C Trial Conducted in Japan
Nov 30, 2015 08:00AM Ironwood Reports Positive Top-Line Data from Phase II Trial of Linaclotide in Adult Patients With Opioid-Induced Constipation
Nov 4, 2015 04:05PM Ironwood Pharmaceuticals to Present at Credit Suisse 24th Annual Healthcare Conference
Nov 3, 2015 04:05PM Ironwood Pharmaceuticals Provides Third Quarter 2015 Investor Update
Nov 3, 2015 08:00AM Ironwood Pharmaceuticals Initiates Clinical Studies of Soluble Guanylate Cyclase Stimulators IW-1973 and IW-1701
Nov 2, 2015 08:00AM Ironwood and Allergan Initiate Phase IIb Clinical Trial of Linaclotide Colonic Release in Adults with Irritable Bowel Syndrome with Constipation
Oct 27, 2015 03:30AM Allergan Acquires Rights To Ironwood's CONSTELLA® (Linaclotide) From Almirall In More Than 40 Countries
Oct 19, 2015 08:00AM Ironwood Highlights Refractory GERD and Constipation Research at the American College of Gastroenterology 2015 Annual Scientific Meeting
Oct 14, 2015 04:01PM Ironwood Pharmaceuticals to Host Third Quarter 2015 Investor Update Call
Oct 13, 2015 04:01PM Ironwood Reports Positive Top-Line Results from Phase III Trial of 72 mcg Linaclotide in Adults with Chronic Idiopathic Constipation
Sep 10, 2015 04:01PM Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
Aug 5, 2015 04:01PM Ironwood Pharmaceuticals Provides Second Quarter 2015 Investor Update
Aug 5, 2015 09:25AM Ironwood and Allergan Enter Agreement to Co-Promote VIBERZI for Irritable Bowel Syndrome with Diarrhea (IBS-D) in the U.S.
View More Recent Stories View Older Stories